Lexeo Therapeutics, Inc. (LXEO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
4:11 pm
Sale
2026-09-3013GLEXEO THERAPEUTICS INC
LXEO
Paradigm BioCapital Advisors LP0
0.000%
-4,175,382decrease
(Position Closed)
Filing
History
2026-11-16
12:24 pm
Sale
2026-09-3013GLEXEO THERAPEUTICS INC
LXEO
Janus Henderson Group Ltd.
JHG
5,936,653
7.200%
-1,354,781decrease
(-18.58%)
Filing
History
2026-11-16
06:06 am
Purchase
2026-09-3013GLEXEO THERAPEUTICS INC
LXEO
Balyasny Asset Management L.P.8,196,420
9.990%
352,109increase
(+4.49%)
Filing
History
2026-11-13
4:16 pm
Purchase
2026-09-3013GLEXEO THERAPEUTICS INC
LXEO
Affinity Asset Advisors, LLC8,112,913
9.800%
1,438,000increase
(+21.54%)
Filing
History
2026-11-10
08:31 am
Sale
2026-09-3013GLEXEO THERAPEUTICS INC
LXEO
STATE STREET CORP
STT
3,594,095
4.400%
-760,680decrease
(-17.47%)
Filing
History
2026-10-13
1:37 pm
Purchase
2026-09-3013GLEXEO THERAPEUTICS INC
LXEO
JPMORGAN CHASE & CO
JPM
4,573,701
5.500%
4,573,701increase
(New Position)
Filing
History
2026-08-14
5:36 pm
Purchase
2026-06-3013GLEXEO THERAPEUTICS INC
LXEO
ORBIMED ADVISORS LLC3,203,050
4.100%
3,203,050increase
(New Position)
Filing
History
2026-08-14
4:22 pm
Sale
2026-06-3013GLEXEO THERAPEUTICS INC
LXEO
Paradigm BioCapital Advisors LP4,175,382
5.300%
-2,008,752decrease
(-32.48%)
Filing
History
2026-08-14
06:04 am
Purchase
2026-06-3013GLEXEO THERAPEUTICS INC
LXEO
Balyasny Asset Management L.P.7,844,311
9.990%
668,167increase
(+9.31%)
Filing
History
2026-08-13
4:12 pm
Purchase
2026-06-3013GLEXEO THERAPEUTICS INC
LXEO
Affinity Asset Advisors, LLC6,674,913
8.400%
1,457,253increase
(+27.93%)
Filing
History
2026-08-07
10:02 am
Purchase
2026-06-3013GLEXEO THERAPEUTICS INC
LXEO
STATE STREET CORP
STT
4,354,775
5.500%
4,354,775increase
(New Position)
Filing
History
2026-05-15
4:25 pm
Purchase
2026-03-3113GLEXEO THERAPEUTICS INC
LXEO
Paradigm BioCapital Advisors LP6,184,134
8.300%
1,420,936increase
(+29.83%)
Filing
History
2026-05-15
06:23 am
Sale
2026-03-3113GLEXEO THERAPEUTICS INC
LXEO
Balyasny Asset Management L.P.7,176,144
9.690%
-45,411decrease
(-0.63%)
Filing
History
2026-04-13
5:03 pm
Purchase
2026-04-0613GLEXEO THERAPEUTICS INC
LXEO
Montanova Capital, LLC5,674,778
7.700%
5,674,778increase
(New Position)
Filing
History
2026-03-27
10:16 am
Sale
2026-03-1313GLEXEO THERAPEUTICS INC
LXEO
VANGUARD GROUP INC0
0.000%
-3,894,310decrease
(Position Closed)
Filing
History
2026-02-17
4:38 pm
Purchase
2025-12-3113GLEXEO THERAPEUTICS INC
LXEO
Citadel Advisors LLC5,498,219
7.400%
164,107increase
(+3.08%)
Filing
History
2026-02-17
4:02 pm
Purchase
2025-12-3113GLEXEO THERAPEUTICS INC
LXEO
Paradigm BioCapital Advisors LP4,763,198
6.500%
1,091,199increase
(+29.72%)
Filing
History
2026-02-17
06:39 am
Purchase
2025-12-3113GLEXEO THERAPEUTICS INC
LXEO
Balyasny Asset Management L.P.7,221,555
9.890%
1,826,834increase
(+33.86%)
Filing
History
2026-02-13
5:33 pm
Purchase
2025-12-3113GLEXEO THERAPEUTICS INC
LXEO
Frazier Life Sciences Public Fund, L.P.3,698,271
5.100%
624,804increase
(+20.33%)
Filing
History
2026-01-30
2:18 pm
Purchase
2025-12-3113GLEXEO THERAPEUTICS INC
LXEO
VANGUARD GROUP INC3,894,310
5.330%
3,894,310increase
(New Position)
Filing
History
Goto 0, 1, 2, 3, Next